0-32259
|
94-3267295
|
(Commission
File Number)
|
(IRS
Employer Identification
No.)
|
881
Martin Avenue, Santa Clara, California
|
95050
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
Exhibit
No.
|
Description
|
|
99.1
|
Press
Release of Align Technology, Inc. dated July 23,
2009
|
Dated:
July 23, 2009
|
ALIGN
TECHNOLOGY, INC.
|
|
By:
|
/s/Kenneth B. Arola
|
|
Kenneth
B. Arola
|
||
Vice
President, Finance and Chief Financial
Officer
|
Exhibit
No.
|
Description
|
|
99.1
|
Press
Release of Align Technology, Inc. dated July 23,
2009
|
|
Press Contact
|
|
Shirley
Stacy
|
Shannon
Mangum Henderson
|
Align
Technology, Inc.
|
Ethos
Communication, Inc.
|
(678)
261-7803
|
|
sstacy@aligntech.com
|
align@ethoscommunication.com
|
·
|
Net
revenues increased 9% sequentially to $76.3
million
|
·
|
International
revenues increased 27% sequentially to $18.1 million or 24% of worldwide
revenues
|
·
|
Invisalign
Teen cases increased 53% sequentially to 11% of worldwide
cases
|
·
|
GAAP
diluted EPS of $0.07 exceeded outlook of breakeven to a
penny
|
Key
GAAP Operating Results
|
Q2 09 | Q1 09 | Q2 08 | |||||||||
Gross
Margin
|
76.0 | % | 75.2 | % | 74.7 | % | ||||||
Operating
Expense
|
$ | 51.7M | $ | 47.4M | $ | 55.8M | ||||||
Operating
Margin
|
8.2 | % | 7.5 | % | 4.8 | % | ||||||
Net
Profit
|
$ | 4.5M | $ | 2.6M | $ | 4.0M | ||||||
Earnings
Per Diluted Share (EPS)
|
$ | 0.07 | $ | 0.04 | $ | 0.06 | ||||||
Key
Non-GAAP Operating Results
|
Q2 09 | Q1 09 | Q2 08 | |||||||||
Non-GAAP
Operating Expense
|
$ | 51.3M | $ | 46.5M | $ | 55.8M | ||||||
Non-GAAP
Operating Margin
|
8.7 | % | 8.8 | % | 4.8 | % | ||||||
Non-GAAP
Net Profit
|
$ | 4.8M | $ | 3.2M | $ | 4.0M | ||||||
Non-GAAP
Earnings Per Diluted Share (EPS)
|
$ | 0.07 | $ | 0.05 | $ | 0.06 |
Revenue
by Channel ($M):
|
Q2
09
|
%
of Total
Revenue
|
Q2
09/Q1 09
%
Change
|
|||||||||
North
American Orthodontists
|
$ | 21.6 | 28.3 | % | 2.3 | % | ||||||
North
American GP Dentists
|
$ | 31.7 | 41.6 | % | 2.7 | % | ||||||
International
|
$ | 18.1 | 23.6 | % | 26.6 | % | ||||||
Non-case
Revenue*
|
$ | 4.9 | 6.5 | % | 27.6 | % | ||||||
Total
Revenue
|
$ | 76.3 | 100 | % | 8.8 | % | ||||||
*includes
training, ancillary products, and retainers
|
||||||||||||
Cases
Shipped by Channel:
|
Q2
09
|
%
of Total
Cases
|
Q2
09/Q1 09
%
Change
|
|||||||||
North
American Orthodontists
|
17,470 | 33.0 | % | 3.4 | % | |||||||
North
American GP Dentists
|
23,525 | 44.4 | % | 0.8 | % | |||||||
International
|
12,010 | 22.6 | % | 22.1 | % | |||||||
Total
Cases Shipped
|
53,005 | 100 | % | 5.9 | % | |||||||
Cases
Shipped by Product:
|
Q2
09
|
%
of Total
Cases
|
Q2
09/Q1 09
%
Change
|
|||||||||
Invisalign
Full
|
37,840 | 71.4 | % | 1.6 | % | |||||||
Invisalign
Express
|
8,000 | 15.1 | % | (0.1 | )% | |||||||
Invisalign
Teen
|
5,940 | 11.2 | % | 52.5 | % | |||||||
Invisalign
Assist
|
1,225 | 2.3 | % | 34.7 | % | |||||||
Total
Cases Shipped
|
53,005 | 100 | % | 5.9 | % |
Average
Selling Price (ASP), as billed:
|
Q2
09
|
|||
Total
Worldwide Blended ASP
|
$
|
1,400
|
||
International
ASP
|
$
|
1,530
|
Number
of Doctors Cases were Shipped to:
|
Q2
09
|
|||
North
American Orthodontists
|
3,750
|
|||
North
American GP Dentists
|
10,630
|
|||
International
|
3,385
|
|||
Total
Doctors Cases were Shipped to Worldwide
|
17,765
|
Number
of Doctors Trained Worldwide:
|
Q2
09
|
Cumulative
|
||||||
North
American Orthodontists
|
65
|
8,805
|
||||||
North
American GP Dentists
|
900
|
34,375
|
||||||
International
|
515
|
15,030
|
||||||
Total
Doctors Trained Worldwide
|
1,480
|
58,210
|
Doctor
Utilization Rates*:
|
Q2
09
|
Q1
09
|
Q2
08
|
|||||||||
North
American Orthodontists
|
4.7
|
4.6
|
4.9
|
|||||||||
North
American GP Dentists
|
2.2
|
2.2
|
2.5
|
|||||||||
International
|
3.6
|
3.2
|
3.3
|
|||||||||
Total
Utilization Rate
|
3.0
|
2.9
|
3.1
|
Total
Invisalign Patients (cases shipped):
|
Q2
09
|
Cumulative
|
||||||
Number
of Patients Treated or in Treatment (cases)
|
53,005 | 1,047,120 |
Three
Months Ended
|
Six
Months Ended
|
|||||||||||||||
|
June
30,
2009
|
June
30,
2008
|
June
30,
2009
|
June
30,
2008
|
||||||||||||
Net
revenues
|
$ | 76,316 | $ | 79,902 | $ | 146,448 | $ | 154,678 | ||||||||
Cost
of revenues
|
18,338 | 20,243 | 35,763 | 39,851 | ||||||||||||
Gross
profit
|
57,978 | 59,659 | 110,685 | 114,827 | ||||||||||||
Operating
expenses:
|
||||||||||||||||
Sales
and marketing
|
29,108 | 32,464 | 56,962 | 60,523 | ||||||||||||
General
and administrative
|
16,539 | 16,322 | 30,007 | 31,510 | ||||||||||||
Research
and development
|
5,669 | 7,001 | 10,860 | 14,296 | ||||||||||||
Restructuring
|
409 | - | 1,319 | - | ||||||||||||
Total
operating expenses
|
51,725 | 55,787 | 99,148 | 106,329 | ||||||||||||
Profit
from operations
|
6,253 | 3,872 | 11,537 | 8,498 | ||||||||||||
Interest
and other income, net
|
557 | 443 | 705 | 1,409 | ||||||||||||
Profit
before income taxes
|
6,810 | 4,315 | 12,242 | 9,907 | ||||||||||||
Provision
for income taxes
|
(2,265 | ) | (285 | ) | (5,061 | ) | (573 | ) | ||||||||
Net
profit
|
$ | 4,545 | $ | 4,030 | $ | 7,181 | $ | 9,334 | ||||||||
Net
profit per share
|
||||||||||||||||
-
basic
|
$ | 0.07 | $ | 0.06 | $ | 0.11 | $ | 0.14 | ||||||||
-
diluted
|
$ | 0.07 | $ | 0.06 | $ | 0.11 | $ | 0.13 | ||||||||
Shares
used in computing net profit per share
|
||||||||||||||||
-
basic
|
66,285 | 68,581 | 66,135 | 68,817 | ||||||||||||
-
diluted
|
67,373 | 69,916 | 66,941 | 70,478 |
June
30,
2009
|
December
31,
2008
|
|||||||
ASSETS
|
||||||||
Current
assets:
|
||||||||
Cash
and cash equivalents
|
$ | 122,182 | $ | 87,100 | ||||
Marketable
securities, short-term
|
20,895 | 23,066 | ||||||
Accounts
receivable, net
|
53,236 | 52,362 | ||||||
Inventories,
net
|
2,111 | 1,965 | ||||||
Other
current assets
|
15,324 | 13,414 | ||||||
Total
current assets
|
213,748 | 177,907 | ||||||
Property
and equipment, net
|
24,518 | 26,979 | ||||||
Goodwill
and intangible assets, net
|
6,866 | 8,266 | ||||||
Deferred
tax asset
|
61,133 | 61,696 | ||||||
Other
long-term assets
|
1,529 | 4,493 | ||||||
Total
assets
|
$ | 307,794 | $ | 279,341 | ||||
LIABILITIES
AND STOCKHOLDERS' EQUITY
|
||||||||
Current
liabilities:
|
||||||||
Accounts
payable
|
$ | 6,473 | $ | 5,580 | ||||
Accrued
liabilities
|
40,200 | 38,282 | ||||||
Deferred
revenue
|
23,138 | 16,710 | ||||||
Total
current liabilities
|
69,811 | 60,572 | ||||||
Other
long term liabilities
|
205 | 229 | ||||||
Total
liabilities
|
70,016 | 60,801 | ||||||
Total
stockholders' equity
|
237,778 | 218,540 | ||||||
Total
liabilities and stockholders' equity
|
$ | 307,794 | $ | 279,341 |
Reconciliation
of GAAP to Non-GAAP Operating Expenses
|
||||||||||||
(in
thousands)
|
||||||||||||
Three
Months Ended
|
||||||||||||
June
30,
2009
|
March
31,
2009
|
June
30,
2008
|
||||||||||
GAAP
Operating expenses
|
$ | 51,725 | $ | 47,423 | $ | 55,787 | ||||||
Restructuring
|
(409 | ) | (910 | ) | - | |||||||
Non-GAAP
Operating expenses
|
$ | 51,316 | $ | 46,513 | $ | 55,787 | ||||||
Reconciliation
of GAAP to Non-GAAP Profit from Operations
|
||||||||||||
(in
thousands)
|
||||||||||||
Three
Months Ended
|
||||||||||||
June
30,
2009
|
March
31,
2009
|
June
30,
2008
|
||||||||||
GAAP
Profit from Operations
|
$ | 6,253 | $ | 5,284 | $ | 3,872 | ||||||
Restructuring
|
409 | 910 | - | |||||||||
Non-GAAP
Profit from Operations
|
$ | 6,662 | $ | 6,194 | $ | 3,872 | ||||||
Reconciliation
of GAAP to Non-GAAP Net Profit
|
||||||||||||
(in
thousands, except per share amounts)
|
||||||||||||
Three
Months Ended
|
||||||||||||
June
30,
2009
|
March
31,
2009
|
June
30,
2008
|
||||||||||
GAAP
Net profit
|
$ | 4,545 | $ | 2,636 | $ | 4,030 | ||||||
Restructuring
|
409 | 910 | - | |||||||||
Tax
effect on non-GAAP adjustments
|
(127 | ) | (355 | ) | - | |||||||
Non-GAAP
Net profit
|
$ | 4,827 | $ | 3,191 | $ | 4,030 | ||||||
Diluted
Net profit per share:
|
||||||||||||
GAAP
|
$ | 0.07 | $ | 0.04 | $ | 0.06 | ||||||
Non-GAAP
|
$ | 0.07 | $ | 0.05 | $ | 0.06 | ||||||
Shares
used in computing diluted net profit per share
|
67,373 | 66,447 | 69,916 |
Q3
2009
|
||||
Net
Revenue
|
$71.0
- $74.5
|
|||
Gross
Margin
|
75.0%
- 75.5%
|
|||
|
||||
Operating
Expenses
|
$49.0
- $50.5
|
|||
Operating
Margin
|
6%
- 8%
|
|||
|
||||
Net
Income per Diluted Share
|
$0.03
- $0.05
|
|||
Stock
Based Compensation Expense:
|
||||
Cost
of Revenues
|
$0.4
|
|||
Operating
Expenses
|
$4.2
|
|||
Total
Stock Based Compensation Expense
|
$4.6
|
|||
Business
Metrics:
|
||||
Q3
2009
|
||||
Case
Shipments
|
51.0K
- 53.0K
|
|||
Cash
|
$150M
- $155M
|
|||
DSO
|
mid
60's
|
|||
Capex
|
$2.0M
- $4.0M
|
|||
Depreciation
& Amortization
|
$2.0M
- $3.0M
|
|||
Diluted
Shares Outstanding
|
68M
|
|||
Full
Year 2009:
|
FY
2009
|
|||
Stock
Based compensation
|
$16.8M
|
|||
Diluted
Shares Outstanding
|
68M
|